National Heart, Lung, and Blood Institute resources and programs for cell-based therapies
JW Thomas - Circulation research, 2007 - Am Heart Assoc
For more than three decades the National Heart, Lung, and Blood Institute (NHLBI) has
supported research and sponsored programs in basic cell biology and stem cell research …
supported research and sponsored programs in basic cell biology and stem cell research …
CHIPping away at the pathogenesis of heart failure
A new window has just opened, illuminating a novel and unsuspected aspect of the
pathogenesis of heart failure. As we age, we accumulate somatic mutations in bone marrow …
pathogenesis of heart failure. As we age, we accumulate somatic mutations in bone marrow …
Multiple somatic mutations for clonal hematopoiesis are associated with increased mortality in patients with chronic heart failure
S Cremer, K Kirschbaum, A Berkowitsch… - Circulation: Genomic …, 2020 - Am Heart Assoc
Clonal hematopoiesis of indeterminate potential (CHIP) is defined as a clonal outgrowth of
hematopoietic cells with mutations in a restricted set of cancer driver genes in patients …
hematopoietic cells with mutations in a restricted set of cancer driver genes in patients …
Clonal Hematopoiesis and Incident Heart Failure With Preserved Ejection Fraction
Importance Clonal hematopoiesis of indeterminate potential (CHIP), the age-related clonal
expansion of hematopoietic stem cells with leukemogenic acquired genetic variants, is …
expansion of hematopoietic stem cells with leukemogenic acquired genetic variants, is …
Clonal haematopoiesis and cardiovascular disease: how low can you go?
MA Evans, S Sano, K Walsh - European Heart Journal, 2021 - academic.oup.com
Clonal haematopoiesis and cardiovascular disease: how low can you go? Page 1 ...........................................................................................................
Clonal haematopoiesis and cardiovascular disease: how low can you go? Megan A. Evans …
Clonal haematopoiesis and cardiovascular disease: how low can you go? Megan A. Evans …
Bone marrow transplantation for the heart: fact or fiction?
RJ Laham, P Oettgen - The Lancet, 2003 - thelancet.com
Substantial advances in the past three decades, including risk-factor modification, use of
anticoagulants and antiplatelet agents, β blockers, angiotensin-convertingenzyme inhibitors …
anticoagulants and antiplatelet agents, β blockers, angiotensin-convertingenzyme inhibitors …
Clonal hematopoiesis and risk of progression of heart failure with reduced left ventricular ejection fraction
DA Pascual-Figal, A Bayes-Genis, M Díez-Díez… - Journal of the American …, 2021 - jacc.org
Background Clonal hematopoiesis driven by somatic mutations in hematopoietic cells,
frequently called clonal hematopoiesis of indeterminate potential (CHIP), has been …
frequently called clonal hematopoiesis of indeterminate potential (CHIP), has been …
Clonal Hematopoiesis: Getting to the Heart of the Problem With Clone Size
K Walsh, JD Cochran, MA Evans - Heart Failure, 2024 - jacc.org
age-associated condition whereby a proportion of mature blood cells originate from a single
dominant hematopoietic stem cell (HSC) clone. This phenomenon can arise from a somatic …
dominant hematopoietic stem cell (HSC) clone. This phenomenon can arise from a somatic …
Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure
L Dorsheimer, B Assmus, T Rasper… - JAMA …, 2019 - jamanetwork.com
Importance Somatic mutations causing clonal expansion of hematopoietic cells (clonal
hematopoiesis of indeterminate potential [CHIP]) are increased with age and associated …
hematopoiesis of indeterminate potential [CHIP]) are increased with age and associated …